We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

195 hedge funds and large institutions have $51M invested in Editas Medicine in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $668K | Put options by funds: $339K

6% less funds holding

Funds holding: 207 → 195 (-12)

8.81% less ownership

Funds ownership: 61.84% → 53.03% (-8.8%)

21% less capital invested

Capital invested by funds: $64.8M → $51M (-$13.8M)

28% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 61

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
195
Holders Change
-12
Holders Change %
-5.8%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
44
Reduced
61
Closed
34
Calls
$668K
Puts
$339K
Net Calls
+$329K
Net Calls Change
+$321K

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$2.1M
2
Morgan Stanley
Morgan Stanley
New York
+$1.65M
3
Bank of America
Bank of America
North Carolina
+$1.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$946K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$822K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.62M
2
Goldman Sachs
Goldman Sachs
New York
-$1.79M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.65M
4
MAM
Monaco Asset Management
Monaco
-$1.36M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
101
Wolverine Trading
Illinois
$14.4K -$33.3K -22,655 -66%
HighTower Advisors
102
HighTower Advisors
Illinois
$12.8K -$147 -100 -0.9%
FPAS
103
Focus Partners Advisor Solutions
Missouri
$12.8K +$16.2K +11,002 New
KCP
104
Kera Capital Partners
California
$12.3K -$650 -442 -4%
TC
105
TownSquare Capital
Utah
$12.2K -$103 -70 -0.7%
Pathstone Holdings
106
Pathstone Holdings
New Jersey
$12.2K -$405 -275 -3%
KOC
107
Koss-Olinger Consulting
Florida
$12K – – –
GWM
108
Gibbs Wealth Management
Georgia
$12K -$37 -25 -0.2%
Russell Investments Group
109
Russell Investments Group
United Kingdom
$12K -$55K -37,403 -78%
AI
110
Atom Investors
Texas
$11.9K +$15.1K +10,275 New
RBI
111
Raiffeisen Bank International
Austria
$11.6K – – –
Canada Life
112
Canada Life
Manitoba, Canada
$10K +$1.9K +1,288 +18%
AIP
113
Ameritas Investment Partners
Nebraska
$9.56K – – –
Zurich Cantonal Bank
114
Zurich Cantonal Bank
Switzerland
$7.6K +$118 +80 +1%
CIBC Private Wealth Group
115
CIBC Private Wealth Group
Georgia
$7.16K – – –
California State Teachers Retirement System (CalSTRS)
116
California State Teachers Retirement System (CalSTRS)
California
$6.97K – – –
FDCDDQ
117
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.38K +$7.36K +5,000 +1,000%
IA
118
IFP Advisors
Florida
$5.8K +$7.3K +4,966 +14,606%
New York State Common Retirement Fund
119
New York State Common Retirement Fund
New York
$5.1K – – –
AWM
120
Activest Wealth Management
Florida
$4.64K – – –
National Bank of Canada
121
National Bank of Canada
Quebec, Canada
$3.46K – – –
US Bancorp
122
US Bancorp
Minnesota
$3.46K -$4.53K -3,076 -51%
SS
123
SBI Securities
Japan
$3.44K +$215 +146 +5%
Mirae Asset Global Investments
124
Mirae Asset Global Investments
South Korea
$3.4K -$43 -29 -1%
AB
125
Amalgamated Bank
New York
$3K – – –
3 4
5
6 7

EDIT Hedge Fund Activity: Q1 2025 in Review

195 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2025, worth a combined $51M — down 21% from $64.8M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of EDIT and 23 opened new positions — a net loss of 11 holders — while 61 trimmed existing stakes and 44 added.

The largest buyer was UBS AM, adding an estimated $2.1M. The largest seller was Millennium Management, cutting an estimated $3.62M.

  • 195 institutional investors held Editas Medicine (EDIT) as of Q1 2025, down from 207 in Q4 2024.
  • Funds reported $51M of Editas Medicine stock for Q1 2025, down 21% quarter-over-quarter.
  • 23 funds opened new Editas Medicine positions in Q1 2025 and 34 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q1 2025 was UBS AM, an estimated $2.1M added.
  • The largest Editas Medicine seller in Q1 2025 was Millennium Management, an estimated $3.62M sold.

Based on aggregated 13F filings for Q1 2025.